Three provinces to study 2-dose HPV vaccine.
Eggertson
Laura
L
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001955:British Columbia; D002648:Child; D005260:Female; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D007115:Immunization Schedule; D009674:Nova Scotia; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics; D011792:Quebec; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control* / Q000821:virology*
D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines